We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. D-mannose alleviates intervertebral disc degeneration through glutamine metabolism

    Background

    Intervertebral disc degeneration (IVDD) is a multifaceted condition characterized by heterogeneity, wherein the balance between catabolism...

    Zheng-Lin Dong, **n Jiao, ... Hai-Rong Tao in Military Medical Research
    Article Open access 06 May 2024
  2. Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer

    Background

    Effective treatment for patients with advanced thyroid cancer is lacking. Metabolism reprogramming is required for cancer to undergo...

    G.-Q. Zhang, C. **, ... Q.-Y. Luo in Journal of Endocrinological Investigation
    Article Open access 22 February 2024
  3. A Population Pharmacokinetic Analysis of l-Glutamine Exposure in Patients with Sickle Cell Disease: Evaluation of Dose and Food Effects

    Background and Objective

    l -Glutamine is a treatment for children and adults with sickle cell disease. A comprehensive evaluation of the...

    Alina Sadaf, Min Dong, ... Charles T. Quinn in Clinical Pharmacokinetics
    Article Open access 24 February 2024
  4. Glutamine is a substrate for glycosylation and CA19-9 biosynthesis through hexosamine biosynthetic pathway in pancreatic cancer

    Background

    Carbohydrate antigen 19–9 (CA19-9) is the most widely used biomarker for pancreatic cancer. Since CA19-9 closely correlates with patient...

    Chen Liu, Shengming Deng, ... Guopei Luo in Discover Oncology
    Article Open access 17 February 2023
  5. Targeting Glutamine Metabolism as an Attractive Therapeutic Strategy for Acute Myeloid Leukemia

    Relapse after chemotherapy and hematopoietic stem cell transplantation leads to adverse prognosis for acute myeloid leukemia (AML) patients. As a...

    Yan **ao, Bingbing Hu, ... Liuting Yu in Current Treatment Options in Oncology
    Article Open access 30 May 2023
  6. SLC38A5 promotes glutamine metabolism and inhibits cisplatin chemosensitivity in breast cancer

    Background

    Solute carrier family 38 member 5 (SLC38A5), as an amino acid transporter, play a vital role in cellular biological processes. In this...

    **aowei Shen, Ganggang Wang, ... Weixing Shen in Breast Cancer
    Article 02 November 2023
  7. YAP governs cellular adaptation to perturbation of glutamine metabolism by regulating ATF4-mediated stress response

    Proliferating cells have metabolic dependence on glutamine to fuel anabolic pathways and to refill the mitochondrial carbon pool. The Hippo pathway...

    Minjoong Kim, Sunsook Hwang, ... Seung Min Jeong in Oncogene
    Article 17 August 2023
  8. Magnetic resonance spectroscopy in MELAS syndrome: correlation with CSF and plasma metabolite levels and change after glutamine supplementation

    Purpose

    MELAS syndrome is a genetic disorder caused by mitochondrial DNA mutations. We previously described that MELAS patients had increased CSF...

    María Paz Guerrero-Molina, Ángela Bernabeu-Sanz, ... Jesús González de la Aleja in Neuroradiology
    Article 19 December 2023
  9. Glutamine stabilizes myc via alpha-ketoglutarate and regulates paclitaxel sensitivity

    Metabolic reprogramming wherein the cancer cells exhibit altered energetics is a hallmark of cancer. Although recent discoveries have enhanced our...

    Vikas Bhardwaj, Jun He, Aditi Jain in Medical Oncology
    Article 29 September 2022
  10. Glutamine addiction promotes glucose oxidation in triple-negative breast cancer

    Glutamine is a conditionally essential nutrient for many cancer cells, but it remains unclear how consuming glutamine in excess of growth...

    Lake-Ee Quek, Michelle van Geldermalsen, ... Jeff Holst in Oncogene
    Article Open access 18 July 2022
  11. Glutamine induces remodeling of tight junctions in Caco-2 colorectal cancer cell

    Malignant cells often exhibit significant metabolic alterations, including the utilization of different nutrients to meet energetic and biosynthetic...

    Ching-Ying Huang, Ji-Kai Chen, Wei-Ting Kuo in Medical Oncology
    Article Open access 02 December 2022
  12. RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis

    Cellular senescence provides a protective barrier against tumorigenesis in precancerous or normal tissues upon distinct stressors. However, the...

    Lei Chen, Wen**g Zhang, ... Yangfan Qi in Signal Transduction and Targeted Therapy
    Article Open access 21 April 2023
  13. Cancer-associated fibroblast-specific lncRNA LINC01614 enhances glutamine uptake in lung adenocarcinoma

    Background

    Besides featured glucose consumption, recent studies reveal that cancer cells might prefer “addicting” specific energy substrates from the...

    Tongyan Liu, Chencheng Han, ... Rong Yin in Journal of Hematology & Oncology
    Article Open access 08 October 2022
  14. Effects of glutamine on plasma protein and inflammation in postoperative patients with colorectal cancer: a meta-analysis of randomized controlled trials

    Objective

    To evaluate the effects of glutamine on the plasma protein and inflammatory responses in colorectal cancer (CRC) patients following radical...

    Kai **ong, Guangsong Li, ... Jiang Chen in International Journal of Colorectal Disease
    Article Open access 11 August 2023
  15. L-glutamine for sickle cell disease: more than reducing redox

    Oxidative stress is a major contributor to the pathophysiology of sickle cell disease (SCD) including hemolysis and vaso-occlusive crisis (VOC)....

    Firas Jafri, Gyuhee Seong, ... Seah H. Lim in Annals of Hematology
    Article 14 May 2022
  16. Antitumor activity of mianserin (a tetracyclic antidepressant) primarily driven by the inhibition of SLC1A5-mediated glutamine transport

    Targeting tumor metabolic vulnerabilities such as “glutamine addiction” has become an attractive approach for the discovery of novel antitumor...

    Zelin Duan, Zhiyun Zhou, ... Hongjian Zhang in Investigational New Drugs
    Article 14 July 2022
  17. Integrative analysis reveals that SLC38A1 promotes hepatocellular carcinoma development via PI3K/AKT/mTOR signaling via glutamine mediated energy metabolism

    Although hepatocellular carcinoma (HCC) is rather frequent, little is known about the molecular pathways underlying its development, progression, and...

    Hua-guo Feng, Chuan-xin Wu, ... Bin **ong in Journal of Cancer Research and Clinical Oncology
    Article 06 September 2023
  18. Ammonia scavenger and glutamine synthetase inhibitors cocktail in targeting mTOR/β-catenin and MMP-14 for nitrogen homeostasis and liver cancer

    The glutamine synthetase (GS) facilitates cancer cell growth by catalyzing de novo glutamine synthesis. This enzyme removes ammonia waste from the...

    Alaa Elmetwalli, Aly Nageh, ... Tarek El-Sewedy in Medical Oncology
    Article 29 December 2023
  19. Immunological effects of glutamine supplementation in polytrauma patients in intensive care unit

    Background

    In polytrauma intensive care unit (ICU) patients, glutamine (GLN) becomes a “conditionally essential” amino acid; its role has been...

    Antonella Cotoia, Leonarda Pia Cantatore, ... Gilda Cinnella in Journal of Anesthesia, Analgesia and Critical Care
    Article Open access 24 September 2022
  20. Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer

    Advanced and aggressive prostate cancer (PCa) depends on glutamine for survival and proliferation. We have previously shown that inhibition of...

    Lingfan Xu, Bing Zhao, ... Jiaoti Huang in Oncogene
    Article 20 January 2022
Did you find what you were looking for? Share feedback.